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O B J E C T I V E S The aim of this study was to determine the prognostic value of assessing left atrial
function during dobutamine stress testing.
B A C KG ROUND Left ventricular diastolic dysfunction precedes systolic wall motion abnormalities in
the ischemic cascade. Severity of left ventricular diastolic function during cardiac stress is not characterized
well by current clinical imaging protocols but may be an important prognostic factor. We hypothesized that
abnormal early left atrial emptying measured during dobutamine stress cardiac magnetic resonance will
reﬂect these diastolic changes and may be associated with cardiovascular outcomes.
METHOD S We enrolled 122 consecutive patients referred for dobutamine stress cardiac magnetic
resonance for suspected myocardial ischemia. Left atrial volumes were retrospectively measured by the
biplane area-length method at left ventricular end-systole (VOLmax) and before atrial contraction (VOLbac).
Left atrial passive emptying fraction deﬁned by (VOLmax – VOLbac) 100%/VOLmax and the absolute percent
increase in left atrial passive emptying fraction during dobutamine stress (∆LAPEF) were quantiﬁed.
R E S U L T S Twenty-nine major adverse cardiac events (MACE) occurred during follow-up (median 23
months). By Kaplan-Meier analysis, patients with ∆LAPEF 10.8 (median) experienced higher incidence
of MACE than did patients with a ∆LAPEF 10.8 (p  0.004). By univariable analysis, ∆LAPEF was
strongly associated with MACE (unadjusted hazard ratio for every 10% decrease  1.56, p  0.005). By
multivariable analysis, every 10% decrease in ∆LAPEF carried a 57% increase in MACE, after adjustment
to presence of myocardial ischemia and infarction.
CONC L U S I O N S Reduced augmentation of left atrial passive emptying fraction during dobutamine stress
demonstrated strong associationwithMACE.We speculate that reduced left atrial passive emptying reserve during
inotropic stress may represent underlying diastolic dysfunction and warrants further investigation. (J Am Coll
Cardiol Img 2011;4:378–88) © 2011 by the American College of Cardiology Foundation
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379ardiac stress testing has traditionally con-
centrated on the imaging and electrical
properties of the left ventricle (LV). How-
ever, it is increasingly recognized that LV
iastolic and systolic performance are intimately
onnected to left atrial (LA) function and size
1–5). For example, impaired relaxation and in-
reased stiffness of the LV, which occur at the
arliest stages of ischemia, alter LA loading
onditions resulting in changes in atrial function
See page 389
and size (6,7). Many of these changes occur before
any detectable abnormality of LV systolic function
(8,9). Due to the complexity of LA function and
limitations of imaging modalities in quantifying LA
changes, potentially important prognostic and di-
agnostic information regarding the LA during
stress testing has not been studied.
Left atrial function has traditionally been de-
scribed as involving a “reservoir” filling phase during
ventricular systole, a “conduit” or “passive” empty-
ing phase during early diastole, and an active
“contractile” pumping phase in late diastole (1).
The advent of cardiac magnetic resonance (CMR)
imaging with its excellent in-plane spatial resolu-
tion and reproducible scan planes allows us to assess
these LA properties quantitatively during stress
testing. We, therefore, hypothesized that augmen-
tation of LA emptying function measured during
staged dobutamine CMR stress testing may provide
important prognostic information for predicting
cardiac events in a patient cohort with clinical
suspicion of coronary artery disease.
M E T H O D S
Study population. We enrolled 122 consecutive pa-
ients at Brigham and Women’s Hospital, referred
or CMR dobutamine stress evaluation of myocar-
ial ischemia due to symptoms suggestive of coro-
ary artery disease (chest pain or shortness of
reath). Quantitation of LA emptying function was
erformed retrospectively. Patients were excluded if
hey had metallic implants incompatible with
MR, uncontrolled arterial hypertension (baseline
ystolic blood pressure 190 mm Hg or diastolic
lood pressure 100 mm Hg), more than mild
itral regurgitation, atrial fibrillation with uncon-
rolled ventricular response, prior adverse reaction
o dobutamine, and acute myocardial infarction
MI) or sustained ventricular tachycardia 96 h hrior to the study. Antianginal medications includ-
ng oral beta-blockers, calcium channel blockers,
nd nitrates were not stopped before CMR. All
atients provided a detailed history at the time of
MR. A history of high cholesterol was defined by
asting low-density lipoprotein cholesterol 100
g/dl or current treatment with cholesterol-
owering medications. Hypertension was defined by
ersistent resting systolic blood pressure 140 mm
g, diastolic blood pressure 90 mm Hg, or
urrent treatment with blood pressure-lowering
edications. Significant smoking history was de-
ned as 10 pack-years of cigarette smoking.
Twenty-three healthy volunteers (mean age 32
ears, 22% women) with no cardiac history also
nderwent resting cine imaging, to provide com-
arative values in the normal population
sing our new method.
The local institutional review board ap-
roved the entire study protocol and clin-
cal follow-up of patients. Informed con-
ent was obtained from all participants
mmediately before performing CMR.
CMR acquisition. Dobutamine CMR was
performed with a 1.5-T system (CV/i, Gen-
eral Electric Medical Systems, Milwaukee,
Wisconsin) using a 4- to 8-element cardiac
phased-array receiver coil. Noninvasive
monitoring and gating for image acquisition
(9500 monitor, MedRad, Warrendale,
Pennsylvania) were performed continuously
in all cases. Dobutamine was infused at
progressive 5-min stages of 10, 20, 30, and
40 g/kg/min via a separate intravenous
ine. If a resting regional wall motion
bnormality was noted, dobutamine in-
usion was started at 5 g/kg/min (5/10/
20/30/40 g/kg/min) in an attempt to
apture the increased inotropic response of dysfunc-
ional but viable segments. Intravenous boluses of
tropine sulfate (0.25- to 0.4-mg aliquots up to a
aximum total dose of 1.5 mg) were used at 30 or
0 g/kg/min stages to augment the heart rate
esponse. Criteria for termination of dobutamine
nfusion were: 1) achievement of 80% of age-
redicted maximum heart rate; 2) development of
ew systolic wall motion abnormalities; 3) systolic
ypotension (90 mm Hg); 4) systolic hyper-
ension (230 mm Hg); 5) significant chest pain;
nd 6) complex ventricular arrhythmias. All
obutamine-CMR image acquisitions were per-
ormed with electrocardiogram gating and breath-
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380short-axis cines were acquired to cover the entire
ventricle in 8 to 14 parallel slices (8-mm thickness
and 0-mm spacing, spatial resolution 1.5  2 mm,
temporal resolution 45 to 50 ms). Cine images were
obtained in 3 parallel short-axis (the base, mid, and
apex) and 3 radial (3-, 4-, and 2-chamber) views at
baseline and at each stress stage. With progressive
heart rate increase, the views per segment were
lowered (from 16 at rest to the lowest 6) to improve
the temporal resolution (to 20 to 25 ms). During
dobutamine stress, custom display permitted on-
the-fly viewing of LV regional function, either by
infusion stage or by slice location. A nurse con-
trolled the dobutamine infusion and monitored the
patient’s symptoms and electrocardiogram continu-
ously in the scanner room while a physician moni-
tored the acquired images at the imaging console.
Vital signs were checked at each dobutamine infu-
sion stage.
Using a previously described inversion-recovery
pulse sequence (10) (repetition time: 4.8 ms; echo
time: 1.3 ms; in-plane spatial resolution between
1.5 1.8 mm and 1.8 2.1 mm), late gadolinium
nhancement (LGE) images were acquired at
lices matching the baseline cine slice locations
bout 10 to 15 min after intravenous gadolinium–
iethyltriaminepentaacetic acid administration
0.15 to 0.20 mmol/kg; Magnevist, Berlex Phar-
aceuticals, Wayne, New Jersey). We optimized
he inversion time (200 to 300 ms) to null normal
yocardium and adjusted the views per segment
ccording to the patient’s heart rate to minimize
ny image blurring.
CMR analysis. Cine function analysis was performed
offline with standard validated software (QMASS,
Leiden, the Netherlands) (11). An experienced
(level-III CMR-trained) reader manually traced the
endocardial contours of the LA in all cine studies.
Left atrial areas in the 4- and 2-chamber long-axis
views were measured at the end of ventricular
systole, just before atrial contraction, and at the end
of ventricular diastole. Identification of the correct
timing required careful scrolling through the car-
diac cycle frame by frame. Maximum atrial volume
at end-systole was determined as the frame just
before mitral valve opening in early diastole. The
timing of the frame before atrial contraction was
determined as occurring just before the second
upward movement of the mitral annulus away from
the apex (the first movement occurred during early
diastole). This also corresponded to the frame just
before the second opening movement of the mitral
valve in diastole. Minimum atrial volume at end- adiastole was determined as the frame just before
mitral valve closure.
By convention, the inferior LA border was de-
fined as the plane of the mitral annulus and not the
tips of the leaflets (12,13). Similarly, the atrial
appendage, pulmonary veins, and recesses of the
mitral valve were excluded by drawing a straight line
across these structures to adjacent atrial borders.
Atrial length was measured from the midpoint of
the mitral annulus plane to the superior margin of
the LA in both 4- and 2-chamber views. Left atrial
volumes were calculated using the biplane area-
length method that has been validated, by CMR, to
be accurate and reproducible compared with volu-
metric analysis: LA volume  (Area4-chamber) 
(Area2-chamber)  0.85/atrial length (12–14). The
horter atrial length from either the 4- or
-chamber view was used as recommended for this
ormula.
Left atrial volumes were calculated at the end of
entricular systole (VOLmax), just before atrial con-
traction (VOLbac), and at the end of ventricular
iastole (VOLmin). Left atrial volume indexes were
calculated by dividing each of VOLmax, VOLmin,
and VOLbac by the patient’s body surface area
calculated by the DuBois formula. From the LA
volumes, the following parameters of atrial function
were calculated: 1) LA passive emptying fraction
(LAPEF)  (VOLmax – VOLbac)  100%/
VOLmax; 2) LA contractile emptying fraction
(LACEF)  (VOLbac – VOLmin)  100%/
VOLbac; 3) LA reservoir emptying fraction
(LAREF)  (VOLmax – VOLmin)  100%/
VOLmax. For each patient, the maximum
obutamine-induced augmentation of these atrial
unctional parameters was calculated as the maximal
ncrease in absolute percent from rest to stress
LAPEF, LACEF, and LAREF, respectively)
Fig. 1). In 30 randomly selected patients, a second
evel-III CMR trained blinded physician measured
he previously mentioned LA dimensions for as-
essment of interobserver variability.
LV volumes indexed to body surface area and
jection fraction were measured from the short-axis
ine images using the Simpson method. LV mass
as calculated by subtracting the endocardial vol-
me from the epicardial volume at end-diastole and
hen multiplying by the tissue density (1.05 g/ml).
he short-axis LGE imaging stack of 8 to 14
arallel slices covering the entire LV was used to
ssess infarct size. The endocardial and epicardial
ontours on these LGE images were traced manu-
lly. Using a semiautomatic detection algorithm, we
s a
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381applied a signal-intensity threshold of 2 SDs
above a remote reference myocardial region on the
same slice to quantify the total mass extent of any
MI (15).
Wall motion was scored at each dobutamine
stage on a 17-segment model using the 4-point
index recommended by the American Society of
Figure 1. 2-Chamber Cine Images and Corresponding Atrial Vol
at Peak Dobutamine Stress
Atrial volumes at end-systole (VOLmax) and before atrial contraction
passive emptying fraction (LAPEF) is deﬁned as (VOLmax – VOLbac) 
(∆LAPEF) is calculated as the maximum change in LAPEF with dobu
of left atrial passive function with stress (∆LAPEF  17%). Such pat
compared with those with poor augmentation of left passive empt
mentation of left atrial passive function with stress. In fact there waEchocardiography where 1  normal, 2  hypoki-nesia, 3  akinesia, and 4  dyskinesia (13).
Dobutamine-induced wall motion abnormality/
ischemia was defined as the presence of segmental
wall motion grade increment1 during progressive
dobutamine stress, except that a progression of
segmental akinesia to dyskinesia was considered
nonspecific. Apart from the LV apex, a myocardial
s at VOLmax and VOLbac at Rest and
Lbac) are shown at rest and at peak dobutamine stress. Left atrial
0%/VOLmax. Left atrial passive emptying function reserve
ine stress. (A) In this patient there was signiﬁcant augmentation
had signiﬁcantly fewer adverse cardiac events during follow-up
fraction such as shown in (B). In this patient, there was no aug-
deterioration (∆LAPEF  –3%).ume
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382dant findings were observed on both the short-axis
and matching long-axis views.
Follow-up. After CMR, subjects were prospectively
followed for a median of 23 months (range 6 to 54
months). The follow-up period was pre-determined
to begin after at least 6 months had elapsed from
the time of CMR. Patients were contacted once.
Clinical follow-up based on a standard question-
naire was obtained from telephone interviews with
the patients, relatives, physicians, or from hospital
records. Survival status was obtained through a
query of the National Social Security Death Index.
Major adverse cardiac events (MACE) were de-
fined as death from any cause, acute MI, unstable
angina, and development or progression of heart
failure. Unstable angina was defined by hospitaliza-
tion because of chest pain plus either angiographic
coronary stenosis of 70% or significant ischemia
on noninvasive stress testing. Development or pro-
gression of heart failure was defined as either new
hospitalization for heart failure or a need for heart
transplantation. When more than 1 of these events
occurred, the first event was used in the analysis.
Patients who had not experienced a MACE but
were referred to undergo coronary revascularization
(percutaneous approach or coronary bypass graft-
ing) were censored at the time of the coronary
revascularization.
Statistical analysis. All continuous variables were
xpressed as mean  SD. A p value of 0.05 was
onsidered statistically significant. Baseline patient
haracteristics stratified by LAPEF were com-
ared using the 2-tailed t test and Fisher exact test
s appropriate. Interobserver variability was ana-
yzed using the Bland-Altman method (16). In
ddition, kappa values were calculated to assess
nterobserver agreement in categorizing LA func-
ion parameters (LAPEF, LACEF, and LAREF)
s normal or abnormal. Abnormally low LA func-
ion parameters were defined as 2 SDs from the
ean values from our normal population. Kaplan-
eier analyses for MACE between low and high
LAPEF groups were compared by the log-rank
est. We fitted Cox proportional-hazards survival
odels to estimate the unadjusted hazard ratios
HRs) and the 95% confidence intervals (CIs) of all
he variables. For multivariable regression analyses,
e further assessed the association of LAPEF
ith MACE, adjusted to a set of clinical and LV
maging predictors based on the univariable analy-
is. We selected the number of variables in each
ultivariable model to have approximately 1 vari-ble for every 10 events, to reduce overfitting. fnalyses were performed using SAS version 9.1
SAS Institute, Cary, North Carolina). In the mul-
ivariable models, the validity of the proportional-
azards assumption was tested by including a time-
ependent interaction variable for each of the
redictors in each of the models (17). The global test
core in SAS, based on scaled Schoenfeld residuals
as used to test for presence of any time-dependent
ovariates in the models (18). Using this, we found no
vidence of violation of the proportional hazards
ssumption in any of the final multivariable models.
R E S U L T S
Study population. We enrolled 122 consecutive pa-
ients of which 14 (11%) were excluded due to
nability to complete the dobutamine stress test or
oor image quality. Three of these 14 (21%) pa-
ients experienced MACE (1 death, 2 congestive
eart failure admissions) during follow-up. The
emaining 108 patients (67 men, mean age 61  12
ears) constituted the study cohort. Table 1 sum-
arizes the clinical characteristics and CMR find-
ngs of the study population, stratified by median
evel of LAPEF. In some patients, LAPEF dete-
iorated with stress, resulting in a negative value for
LAPEF. In the current study cohort, mean
LAPEF was 11 14% (median 10.8%, interquar-
ile range 23%, range –16% to 41%). Patients with
LAPEF below the median value had lower base-
ine LV ejection fractions at rest, larger LV end-
iastolic and end-systolic volume indexes, and a
rend increase in inducible wall motion deteriora-
ion during progressive dobutamine stress.
Interobserver variability. Table 2 shows resting LA
olumes and LA functional parameters for the
roup of healthy volunteers and study patients.
land-Altman analysis of interobserver variability
or VOLmax, VOLbac, and VOLmin showed a bias
95% limits of agreement) of 1.5  7.9 ml, 1.0 
.8 ml, and 3.2  7.6 ml, respectively. The Bland-
ltman plots showed no systematic bias (Fig. 2). In
ddition, kappa values were calculated to assess
nterobserver agreement in detecting abnormally
ow LA function parameters (LAPEF, LACEF,
nd LAREF). Abnormally low LA function pa-
ameters were defined as 2 SDs of the means of
hese parameters measured from the group of 30
andomly selected patients. The interobserver
greement for detection of abnormally low atrial
unction parameters was good (kappa  0.75 for
APEF, kappa 0.84 for LACEF, and kappa 0.86or LAREF).
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383Univariable association with MACE. A total of 29
ACE (16 deaths, 3 acute MI, 7 unstable
ngina, and 3 congestive heart failure episodes
Table 1. Baseline Characteristics of the Study Population (n  1
Overall
Clinical characteristics
Age, yrs 61 12
Body mass index, kg/m2 29 6
Women, % 38
Diabetes history, % 31
Hypertension history, % 67
CAD history by angiography, % 50
Myocardial infarction history, % 29
CABG history, % 15
PCI history, % 16
High cholesterol history, % 66
Signiﬁcant smoking history, % 46
Peripheral vascular disease history, % 18
Beta-blocker use, % 62
ACE inhibitor use, % 47
Resting systolic blood pressure, mm Hg 144 25
Stress systolic blood pressure, mm Hg 157 37
CMR data
Presence resting WMA, % 38
Presence LGE, % 39
Presence dobutamine-induced WMA, % 27
LV ejection fraction, % 54 15
LV EDV index, ml/m2 181 83
LV ESV index, ml/m2 92 82
LV mass, g 142 50
Infarct size, % of LV mass 5.4 9.4
Mean infarct transmural extent, % 15 11
Values are mean  SD or %.
ACE  angiotensin-converting enzyme; CABG  coronary artery bypass surge
volume; LV  left ventricular; PCI  percutaneous coronary intervention; WMA
Table 2. Left Atrial Volumes and Resting Left Atrial Functional
Parameters in Patients and Healthy Volunteers
Study Patients
(n  108)
Healthy Volunteers
(n  23)
VOLmax, ml 101 35 86 15
VOLmax index, ml/m
2 51 17 42 7
VOLbac, ml 83 32 53 10
VOLbac index, ml/m
2 42 15 27 5
VOLmin, ml 58 32 37 10
VOLmin index, ml/m
2 30 16 17 4
LAPEF, % 18 12 38 5
LACEF, % 32 15 32 10
LAREF, % 44 15 58 7
Values are mean  SD.
LACEF  left atrial contractile emptying fraction; LAPEF  left atrial passive
emptying fraction; LAREF  left atrial reservoir emptying fraction; VOLbac 
left atrial volume before atrial contraction; VOLmax  maximum left atrialsvolume; VOLmin  minimum left atrial volume.equiring hospitalization) occurred during a me-
ian follow-up of 23 months. Figure 3 illustrates
he Kaplan-Meier survival curves stratified by
edian LAPEF. Patients with a LAPEF 
median experienced a worse event-free survival
during the study period than did patients with a
LAPEF  median (p  0.004). Table 3 lists
the univariable predictors of MACE. As a con-
tinuous variable, every 10% decrease in LAPEF
corresponded to an increase in MACE hazards by
56%. Other significant univariable predictors of
MACE included patient age and beta-blocker
use, as well as the imaging variables of
dobutamine-induced wall motion abnormalities,
LGE, and resting LA volume at end-diastole
(VOLmin). Baseline wall motion score index did
ot demonstrate any significant association with
ACE. Both LV ejection fraction of 40% and
nfarct size per 10% change trended toward
Stratiﬁed by Median Level of LAPEF
LAPEF < Median LAPEF > Median p Value
62 10 60 13 0.60
29 6 29 5 0.53
39 37 0.84
36 25 0.30
68 65 0.84
55 45 0.51
34 23 0.29
18 12 0.42
16 15 0.99
68 63 0.69
49 42 0.56
22 13 0.32
69 54 0.12
51 42 0.44
143 22 146 19 0.55
163 29 151 33 0.10
43 33 0.32
48 31 0.10
35 19 0.08
51 17 58 12 0.02
198 98 163 60 0.03
111 101 73 50 0.02
149 50 134 49 0.17
6.2 9.3 4.6 9.5 0.44
14 10 16 12 0.55
D  coronary artery disease; EDV  end-diastolic volume; ESV  end-systolic
all motion abnormalities.08)

ry; CA
 wignificance as univariable predictors of MACE
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384(both p  0.06 and 0.05, respectively). Mean
infarct transmural extent, LACEF, and
LAREF did not demonstrate significant prog-
nostic association with MACE.
Multivariable association with MACE. Table 4 illus-
trates the multivariable analysis of MACE. After
adjustment for the effects of beta-blocker use and
patient age in years (the 2 strongest univariable
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Figure 2. Bland-Altman Analysis of Interobserver Variability
for VOLmax, (VOLbac, and VOLmin)
Bland-Altman analysis of inter-observer variability for (A) VOLmax,
(B) VOLbac, and (C) VOLmin. VOLmin  left atrial volume at end-
diastole; other abbreviations as in Figure 1.clinical predictors of MACE), LAPEF main-tained a strong and independent association with
MACE. Every 10% decrease in LAPEF was
associated with a 57% increase in MACE (p 
0.006). Another multivariable model determined
the prognostic association of LAPEF adjusted to
the effects of dobutamine-induced wall motion
abnormality and presence of LGE (the 2 strongest
univariable LV imaging predictors of MACE).
Adjusting to presence of myocardial scar by LGE
imaging and dobutamine-induced wall motion ab-
normality, every 10% reduction in LAPEF was
associated with a 57% increase in MACE (p 
0.01). When added to the model that consisted of
LGE presence and dobutamine-induced wall mo-
tion abnormality, LAPEF increased the model
likelihood ratio chi-square from 8.76 to 16.00 (p 
0.01). Although increase in wall motion score index
(from baseline to peak dobutamine) was a univari-
able predictor of MACE (Table 3), it had no
significant predictive value after adjustment to
LAPEF (Table 4). In addition, LAPEF main-
ained a significant association with MACE even after
djustment to both presence of LGE and infarct size
adjusted HR: 1.04/10% change in LAPEF, 95%
I: 1.01 to 1.08, p  0.008). Moreover, LAPEF
as associated with MACE independent of the effects
f resting LA size. When adjusted to VOLmin,
LAPEF still provided incremental association with
MACE (adjusted HR: 1.05/10% change in
LAPEF, 95% CI: 1.02 to 1.08, p  0.003).
Prognostic association of LAPEF in patients without
regional wall motion deterioration during progressive
dobutamine stress. Twenty-eight patients (26%)
f the cohort demonstrated deterioration of re-
ional LV wall motion that is indicative of
yocardial ischemia, whereas the other 80 pa-
ients did not. Out of the 80 patients who had no
vidence of ischemia, 16 experienced MACE in
he follow-up period (including 7 deaths, 2 acute
Is, 6 unstable angina hospitalizations, and 1
eart failure hospitalization). In these patients,
LAPEF  median is strongly associated with
ACE despite a lack of evidence for myocardial
schemia by wall motion abnormality. In this
ubset of patients, every 10% reduction of
LAPEF was associated with a 56% increase in
ACE hazards (HR: 1.56, 95% CI: 1.06 to 2.30,
hi-square likelihood ratio: 5.03).
D I S C U S S I O N
To our knowledge, this is the first study to
quantitatively evaluate LA emptying function
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385during cardiac stress testing. Our data indicate
that reduced augmentation of passive LA empty-
ing fraction (LAPEF) is a predictor of cardiac
events. Every 10% decrease in LAPEF is asso-
ciated with a 57% increase in MACE, after
adjusting for presence of inducible ischemia and
myocardial scar. We have provided preliminary
data from a pilot clinical cohort with relatively
few adverse events and consequently limited mul-
tivariable adjustments were possible. Neverthe-
less, these findings are suggestive of a close
inter-relationship between stress-induced LA
and diastolic dysfunction with adverse outcomes.
LA function and ventricular performance. The close
oupling between LV and LA function highlights
he somewhat artificial distinction made between
hese 2 properties (1–5). During LV systole, the
ownward movement of the mitral annulus
tretches the atria so that atrial and ventricular
olumes reciprocate. This is also the case during early
iastolic LA emptying, when ventricular relaxation
nd elastic recoil move the mitral annulus upward,
ignificantly contributing to LV filling. This has led
ome to suggest that these LA functional properties
hould really be thought of as LV properties (19).
Atrial function and MACE. Kizer et al. (20) showed
that LA pumping function at rest can predict
cardiac events in a population-based cohort. We
have shown that an inability to augment LA passive
emptying fraction with stress is a predictor of poor
Figure 3. Kaplan-Meier Survival Curves for MACE for Patients W
In the current clinical cohort, patients with a reduced ∆LAPEF (belo
study follow-up (p  0.004). The number of patients at risk during
Abbreviations as in Figure 1.outcome. Presumably, these patients are unable toincrease early diastolic filling by improving active
relaxation or ventricular suction. Thus, augmenta-
tion of LA passive function may be a measure of
early diastolic functional reserve. We have shown
that ischemia as detected by new or worsening LV
wall motion abnormalities with stress was not an
independent predictor of MACE when adjusted for
the effects of LA passive functional reserve. This
maybe because diastolic abnormalities responsible
for failure of LA passive function augmentation
precede obvious systolic wall motion deterioration
as described in the concept of the ischemic cascade
(8,9,21).
LA function during ischemia. A significant body of
animal and human experimental data has shown
that during an ischemic insult, changes in diastolic
LV function occur before any changes in systolic
wall motion (6–9,21). Thus, relying on detection of
systolic wall motion abnormalities alone may result
in missing some patients with early ischemia. Sim-
ilarly, changes in LA function during angioplasty
have been shown to precede changes in LV systolic
function (7).
There are several possible mechanisms by which
ischemia leads to abnormalities of ventricular filling
early in diastole and thus to a diminution of LA
passive functional reserve (8,22): 1) myocardial
relaxation is an exquisitely energy-dependent pro-
cess and highly sensitive to the effects of ischemia,
because adenosine triphosphate hydrolysis is needed
LAPEF Above and Below the Median
edian of 10.8%) experienced reduced event-free survival during
study follow-up period in each group is listed at the bottom.ith
w m
theto release tightly bound actin-myosin bonds and for
s
m
s
r
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386calcium reuptake into the sarcoplasmic reticulum;
and 2) subendocardial longitudinal fibers are par-
ticularly sensitive to ischemia. This leads to unco-
Table 3. Unadjusted Analysis of HR for Potential Predictors of M
Variable
Unadju
(95%
Age, yrs 1.05 (1.0
Body mass index, kg/m2 0.99 (0.9
Female sex 1.15 (0.5
Diabetes history 1.46 (0.6
Hypertension history 1.90 (0.7
CAD history by angiography 1.26 (0.5
Myocardial infarction history 1.97 (0.9
Beta-blocker use 4.31 (1.5
Resting systolic blood pressure, mm Hg 0.99 (0.9
Stress systolic blood pressure, mm Hg 0.99 (0.9
Left ventricular parameters
Presence of resting WMA 1.73 (0.8
Dobutamine-induced WMA 2.40 (1.1
LV ejection fraction 40% 2.13 (0.9
LV ejection fraction, per 10% increase 0.88 (0.6
LV EDV index, per 10 ml/m2 increase 1.05 (0.9
LV ESV index, per 10 ml/m2 increase 1.05 (0.9
LV mass, g 1.00 (0.9
Presence of LGE 2.71 (1.2
Infarct size, per 10% of LV mass 1.40 (0.9
Mean infarct transmural extent, % 1.01 (0.9
Left atrial parameters
VOLmax, per ml 1.01 (0.9
VOLmax index, per ml/m
2 0.09 (0.9
VOLmin, per ml 1.01 (1.0
VOLmin index, per ml/m
2 1.01 (1.0
Resting LAPEF, per 10% 0.99 (0.9
∆LAPEF, per 10% decrease 1.56 (1.1
∆LACEF, per 10% decrease 0.89 (0.7
∆LAREF, per 10% decrease 1.00 (0.7
The boldfaced values are statistically signiﬁcant.
HR  hazard ratio; LR  likelihood ratio; MACE  major adverse cardiac eve
∆LAPEF  maximum augmentation in left atrial passive emptying fraction; ∆
abbreviations as in Tables 1 and 2.
Table 4. Multivariable Associations of LAPEF* With MACE
Model HR (95% CI) p Value
Adjusted to clinical variables
∆LAPEF* 1.57 (1.14–2.18) 0.006
Patient age 1.04 (1.00–1.09) 0.04
Beta-blocker use 3.14 (1.07–9.24) 0.04
Adjusted to LV imaging variables
∆LAPEF* 1.57 (1.12–2.20) 0.01
Presence of LGE 2.16 (0.76–6.13) 0.15
Dobutamine-induced WMA 1.65 (0.61–4.41) 0.32
*Per every 10% decrease.eAbbreviations as in Tables 1, 2, and 3.ordinated or asynchronous relaxation between cir-
cumferential and longitudinal fibers in ischemic
areas, as well as a reduction in longitudinal contrac-
tile function that may not be initially detectable but
which could lead to diminished ventricular suction.
It should be noted that classical markers of LV
diastolic function were not measured in the current
study. It would be of interest to know if LA
functional parameters (such as LAPEF) are more
ensitive to LV ischemia than classical diastolic
arkers.
Relative prognostic importance of atrial reservoir, passive,
and pump functions. Our study did not show a
ignificant prognostic effect of changes in atrial
eservoir or contractile function on future cardiac
E
HR
) p Value Chi-Square LR
.09) 0.01 7.03
.06) 0.75 0.10
.47) 0.71 0.13
.11) 0.33 0.96
.04) 0.19 1.68
.93) 0.60 0.28
.22) 0.08 3.03
2.46) 0.01 7.32
.01) 0.95 0.01
.01) 0.88 0.02
.66) 0.15 2.09
.24) 0.03 4.82
.69) 0.06 0.27
.12) 0.30 1.06
.13) 0.24 1.35
.13) 0.22 1.46
.01) 0.17 1.90
.14) 0.02 5.73
.96) 0.05 3.81
.06) 0.80 0.07
.02) 0.24 1.39
.01) 0.09 2.79
.02) 0.03 4.53
.01) 0.01 6.73
.02) 0.56 0.34
.11) 0.005 7.85
.08) 0.22 1.50
.27) 0.99 0.01
LACEF  maximum augmentation in left atrial contractile emptying fraction;
F  maximum augmentation in left atrial reservoir emptying fraction; otherAC
sted
CI
1–1
2–1
4–2
9–3
2–5
4–2
2–4
0–1
9–1
9–1
2–3
0–5
7–4
9–1
7–1
7–1
9–1
0–6
9–1
6–1
9–1
9–1
0–1
0–1
6–1
4–2
4–1
9–1
nts; ∆
LAREvents. It has been shown that transient ischemia
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387tends to increase atrial contractile function (the
atrial booster pump), mildly decrease atrial reservoir
function, and profoundly decrease atrial passive
function (6). This suggests that our finding of
prognostic significance only with atrial passive
function may be because it is the most sensitive
marker of ischemia due to the particular energy
dependence of early myocardial relaxation as op-
posed to other aspects of diastolic function.
Study limitations. Given the small study size, the
urrent multivariable models were limited to a few
elected clinical and LV imaging variables. Thus,
e were unable to estimate the association of
LAPEF with MACE when simultaneously ad-
usted to all possible predictors. Also given the small
tudy size, the possibility of selection bias must be
ept in mind, particularly given the relatively high
vent rates that were observed in those with no
tress-induced wall motion abnormalities. At the
ime of this study, stress CMR was not the first line
tress test at our institution. It is therefore likely
hat there was selection bias present with predom-
nantly more complex and sicker patients referred
or this examination. The risk associated with a
egative test is highly dependent on the underlying
opulation risk. For example, others have found
ACE rates in high risk patients with LV dys-transient left ventricular ischemia pro-
1
1
2821–5.round 30% at 24 months (23). Thus although our
vent rates are high in the negative stress test group,
his is likely a reflection of the sick population
tudied.
Finally, although the LA volumes measured in
ur normal subjects are high compared with those
eported in the echocardiographic literature, they
re similar to recently reported CMR reference
anges (40.0  6.7 ml/m2) (24,25).
C O N C L U S I O N S
Augmentation of LA passive emptying fraction
during dobutamine stress, quantified by CMR, is a
predictor of cardiovascular prognosis, independent
of major clinical or LV imaging predictors. Our
findings are consistent with a close relationship
between LA passive emptying function and LV
diastolic dysfunction. However, the mechanisms
linking stress-induced changes in LA function with
adverse outcomes require further study.
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